... and REGN3051, were discovered and developed by scientists at the biotechnology company Regeneron, headquartered in Tarrytown, New York. Subsequently, researchers at Regeneron and the University of Maryland School of Medicine demonstrated the ability ...
https://www.nih.gov/news-events/news-releases/experimental-mers-treatments-enter-clinical-trial
No comments:
Post a Comment